Publications

5803 Results

Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214 [PMID21135270; PMC3056462]

Authors
E Gore;S Wong;A Sun;JA Bonner;SC Schild;L Gaspar;JA Bogart;M Werner-Wasik;H Choy
Journal / Conference
Journal of Clinical Oncology 29(3):272-278
Year
2011
Research Committee(s)
Lung

Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysis. [PMID21135267; PMC3056463]

Authors
A Sun;K Bae;B Movsas;S Wong;CA Meyers;JA Bonner;SE Schild;L Gaspar;J Bogart;M Werner-Wasik;H Choy
Journal / Conference
Journal of Clinical Oncology 29(3):279-286
Year
2011
Research Committee(s)
Lung

A phase III randomized trial of anastrozole versus anastrozole and fulvestrant as first-line therapy for postmenopausal women with metastatic breast cancer: SWOG S0226

Authors
R Mehta;W Barlow;K Albain;T Vandenberg;S Dakhil;N Tirumali;D Lew;D Hayes;J Gralow;R Livingston;G Hortobagyi
Journal / Conference
San Antonio Breast Cancer Symposium 2011 Meeting, abst. S1-1;oral presentation;
Year
2011
Research Committee(s)
Breast
Study Number(s)
S0226

SWOG S0927: A randomized doubled blind placebo-controlled trial of omega-3-fatty acid for the control of aromatase inhibitor (AI)-induced musculoskeletal pain in women with early stage breast cancer

Authors
D Hershman;J Unger;K Crew;C Moinpour;L Minasian;L Hansen;D Lew;K Kaberle;J Wade;F Meyskens
Journal / Conference
San Antonio Breast Cancer Symposium 2011 Meeting, abstract OT2-07-02 (poster);
Year
2011
Research Committee(s)
Symptom Management and Survivorship
Study Number(s)
S0927

A randomized phase III clinical trial of standard adjuvant endocrine therapy in patients (pts) with 1-3 positive nodes, hormone receptor (HR)-positive and HER-2negative breast cancer with recurrence score (RS) of 25 or less: SWOG S1007

Authors
A Gonzalez-Angulo;W Barlow;J Gralow;F Meric-Bernstam;D Hayes;C Moinpour;S Ramsey;A Schott;D Sparks;K Albain;G Hortobagyi
Journal / Conference
San Antonio Breast Cancer Symposium 2011 Meeting, abstract # OT1-03-01;poster presentation;
Year
2011
Research Committee(s)
Breast
Study Number(s)
S1007

Outcome of patients with acute myeloid leukemia with monosomal karyotype who undergo hematopoietic cell transplantation [PMID21680797;PMC3156042]

Authors
M Fang;B Storer;E Estey;M Othus;L Zhang;B Sandmaier;F Appelbaum
Journal / Conference
Blood 118(6):1490-1494
Year
2011
Research Committee(s)
Leukemia
Study Number(s)
S0106, S0112, SWOG-8600, SWOG-9126, SWOG-9333, SWOG-9500

Cytarabine dose for acute myeloid leukemia. (Letter to the Editor) [PMID21631340]

Authors
B Medeiros;M Othus;F Appelbaum
Journal / Conference
New England Journal of Medicine 364(11):2167-2168
Year
2011
Research Committee(s)
Leukemia
Study Number(s)
S0106, S0112, SWOG-8600, SWOG-9031, SWOG-9034 (EST-3489) (CALGB-9120), SWOG-9126, SWOG-9333, SWOG-9500, S9617, S9918

A phase III randomized intergroup trial (SWOG S0016) of CHOP chemotherapy plus rituximab vs. CHOP chemotherapy plus iodine-131 for the treatment of newly diagnosed follicular non- hodgkin's lymphoma

Authors
O Press;J Unger;L Rimsza;J Friedberg;M Leblanc;M Czuczman;M Kaminski;R Braziel;D Maloney;B Cheson;TP Miller;RI Fisher
Journal / Conference
Blood 118:abstract 98; American Society of Hematology Annual Meeting, oral
Year
2011
Research Committee(s)
Lymphoma
Study Number(s)
S0016

Prognostic significance of FLT3 and NPM1 mutations in adults of age 18-60 with de novo acute myeloid leukemia (AML): a study by FHCRC and SWOG

Authors
EL Pogosova-Agadjanyan;K Kopecky;S Petersdorf;H Erba;RM Stone;S Mehinchi;TJ Nevill;J Radich;L Stenke;M Slovak;RK Stuart;M Tallman;C Willman;A Brumbaugh;M Cronk;C Cummings;J Engel;R Mortensen;A Suchanek;F Appelbaum;D Stirewalt
Journal / Conference
Blood 118(21):abst 2520; American Society of Hematology Annual Meeting, poster presentation;
Year
2011
Research Committee(s)
Leukemia
Study Number(s)
S0106

Modified high-dose melphalan and autologous stem cell transplantation (mHDM/SCT) in the treatment of AL amyloidosis (AL) and/or high-risk myeloma (hM): analysis of SWOG trial S0115

Authors
V Sanchorawala;A Hoering;DC Seldin;KT Finn;SA Fennessey;B Mattar;HF Safah;LA Holmberg;RM Dean;RZ Orlowski;B Barlogie
Journal / Conference
Blood 118(21):abstact 2004; American Society of Hematology, poster;
Year
2011
Research Committee(s)
Myeloma
Study Number(s)
S0115